Daniel R. Saltzstein

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer

Neal D. Shore, Fred Saad, Michael S. Cookson et al. · New England Journal of Medicine · 2020 · 436 citations · Full text

Medicine, Oncology, Pharmacology +17

A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer

Dipen J. Parekh, Sanoj Punnen, Daniel D. Sjoberg et al. · European Urology · 2014 · 408 citations

Medicine, Oncology, Urology +17

ONCE DAILY CONTROLLED VERSUS IMMEDIATE RELEASE OXYBUTYNIN CHLORIDE FOR URGE URINARY INCONTINENCE

Rodney U. Anderson, D Mobley, Bruce Blank et al. · The Journal of Urology · 1999 · 294 citations

Medicine, Pharmacotherapy, Urology +16

Prospective Randomized Controlled Trial of Extended-Release Oxybutynin Chloride and Tolterodine Tartrate in the Treatment of Overactive Bladder: Results of the OBJECT Study

Rodney A. Appell, Peter K. Sand, Roger R. Dmochowski et al. · Mayo Clinic Proceedings · 2001 · 245 citations

Medicine, Pharmacology, Urology +9

Efficacy and Safety of Transdermal Oxybutynin in Patients With Urge and Mixed Urinary Incontinence

Roger R. Dmochowski, G. Willy Davila, Norman R. Zinner et al. · The Journal of Urology · 2002 · 209 citations

Medicine, Pharmacotherapy, Urology +14